γδ T cell responses to activated T cells in multiple sclerosis patients induced by T cell vaccination

被引:25
|
作者
Stinissen, P
Zhang, JW
Vandevyver, C
Hermans, G
Raus, J
机构
[1] Dr Willems Inst, Multiple Sclerosis Res Unit, B-3590 Diepenbeek, Belgium
[2] Limburgs Univ Centrum, B-3590 Diepenbeek, Belgium
[3] Dr Willems Inst, Biotechnol Unit, B-3590 Diepenbeek, Belgium
关键词
multiple sclerosis; gamma delta T lymphocytes; immunotherapy; T cell vaccination;
D O I
10.1016/S0165-5728(98)00060-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To explore the hypothesis that gamma delta T cells may regulate activated alpha beta T cells, we studied gamma delta T cell responses to alpha beta T cell clones in Multiple Sclerosis (MS) patients who received attenuated autologous autoreactive T cells. We recently conducted a pilot study of T cell vaccination with myelin basic protein reactive T cells in MS. Since T cell vaccination upregulates the anti-vaccine T cell responses, we evaluated gamma delta T cell reactivity towards the vaccine in the vaccinated patients, Lymphocytes were stimulated in vitro with irradiated vaccine cells and the responding lines were checked for the presence of gamma delta T cells. Our data demonstrate that in the majority of vaccinated MS patients gamma delta T cells expand upon stimulation with the vaccine cells. The responding gamma delta T cells were predominantly V delta 1(+)/V gamma 1(+), and represented diverse clonal origins. The gamma delta T cells could not inhibit in vitro proliferation of the vaccine T cells and displayed low cytotoxic reactivity towards the vaccine clones. However, they produced high levels of IL2, TNF alpha and IL10. These results indicate that gamma delta T cells can be stimulated by activated alpha beta T cells, and that these gamma delta T cell responses are upregulaled after T cell vaccination. These findings suggest that gamma delta T cells are involved in peripheral mechanisms to control activated autoreactive T cells. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:94 / 104
页数:11
相关论文
共 50 条
  • [31] T-CELL VACCINATION IN MULTIPLE-SCLEROSIS - HOPES AND FACTS
    ZHANG, JW
    RAUS, J
    ACTA NEUROLOGICA BELGICA, 1994, 94 (02) : 112 - 115
  • [32] Long-term effects of T cell vaccination in multiple sclerosis
    Stinissen, P
    Hermans, G
    Hellings, N
    Medaer, R
    Raus, J
    TREATMENT OF AUTOIMMUNE DISORDERS, 2003, : 129 - 149
  • [33] CURRENT TREATMENT FOR MULTIPLE-SCLEROSIS - T-CELL VACCINATION
    ZIPP, F
    HOHLFELD, R
    NERVENARZT, 1994, 65 (06): : 424 - 425
  • [34] Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
    Katz, J.
    Bouley, A.
    Lathi, E.
    Douglas, E.
    Jungquist, R. -M.
    O'Shea, I.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 786 - 787
  • [35] Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
    Katz, J. D.
    Bouley, A. J.
    Jungquist, R. M.
    Douglas, E. A.
    O'Shea, I. L.
    Lathi, E. S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [36] Vaccination with autoreactive T cells in the treatment of Multiple Sclerosis
    Correale, J
    MEDICINA-BUENOS AIRES, 2000, 60 (05) : 722 - 722
  • [37] Anti-ergotypic T cell responses in healthy controls and multiple sclerosis patients
    Hellings, N
    Govarts, C
    Raus, J
    Stinissen, P
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 210 - 210
  • [38] T CELL RESPONSES B cells control T cell traffic
    Kugelberg, Elisabeth
    NATURE REVIEWS IMMUNOLOGY, 2015, 15 (06) : 332 - 333
  • [39] Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis
    von Essen, Marina Rode
    Hansen, Rikke Holm
    Hojgaard, Camilla
    Ammitzboll, Cecilie
    Wiendl, Heinz
    Sellebjerg, Finn
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (04):
  • [40] COVID-19 humoral and T-cell mediated vaccination responses in people with multiple sclerosis
    Vickaryous, N.
    Rios, F.
    Schalk, L.
    Asardag, A. N.
    George, K.
    Kang, A.
    Baker, D.
    Giovannoni, G.
    Dobson, R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 680 - 680